Lulifin Max Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections of the skin. Luliconazole exhibits broad-spectrum antifungal activity against dermatophytes, yeasts, and molds by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting cell membrane integrity and leading to fungal cell death. This cream is primarily prescribed for conditions such as tinea corporis, tinea cruris, tinea pedis, and candidal infections. Lulifin Max Cream is applied once daily to the affected area and surrounding skin after thorough cleansing and drying, typically for a duration of 2 to 4 weeks depending on the severity and type of infection. It is well-tolerated with minimal systemic absorption, reducing the risk of systemic side effects. Common adverse reactions may include mild local irritation, burning sensation, or erythema at the application site. The cream should not be used in individuals with known hypersensitivity to luliconazole or any of the cream’s excipients. Caution is advised when applying near mucous membranes or broken skin. Lulifin Max Cream offers an effective and convenient topical antifungal option for managing dermatophytic and candidal infections.